Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Karakaya, J. Grutters, C. van Moorsel, A. van der Helm-van Mil, T. Huizinga, H. Ruven, J. van den Bosch (Nieuwegein, Leiden, Netherlands). Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical phenotypes of Löfgren‘s syndrome. Eur Respir J 2009; 34: Suppl. 53, 3128

Member's Comments

No comment yet.

Related content which might interest you: Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population Source: Eur Respir J 2007; 29: 325-329 Year: 2007 Genetic polymorphism in the human tumor necrosis factor (TNF) and its association with different clinical types of tuberculosis disease in Peruvian patients Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004 Frequency and significance of vascular endothelial growth factor (VEGF) 936 C/T polymorphism in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002 TNF-alpha and TNF-beta gene polymorphism in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Association between polymorphism of tumour necrosis factor α -308 gene promotor and asthma: a meta-analysis Source: Eur Respir J 2006; 28: Suppl. 50, 524s Year: 2006 Macrophage migration inhibitory factor (MIF) promoter polymorphisms are associated with favorable hemodynamic indices in systemic sclerosis-associated pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Vascular endothelial growth factor and tumor necrosis factor gene polymorphisms in Turkish patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Tumour necrosis factor gene polymorphisms are associated with COPD Source: Eur Respir J 2008; 31: 1005-1012 Year: 2008 Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD Source: Eur Respir J 2007; 30: 810-812 Year: 2007 Association of TNF, IL8, NOS1, NOS3 and NRAMP1 gene polymorphisms with COPD exacerbation etiology Source: Eur Respir J 2005; 26: Suppl. 49, 95s Year: 2005 Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis Source: Eur Respir J 2011; 37: 169-175 Year: 2011 Frequency of TNFα and TNF receptor-1 polymorphisms in SSc patients with and without lung involvement Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 Transforming growth factor beta (TGFβ)-2 and -3 gene polymorphisms in different phenotypes of sarcoidosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007 Nerve growth factor (NGF) gene polymorphism in allergic asthma Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 Involvement of RANTES gene promoter polymorphisms in the susceptibility for childhood asthma Source: Eur Respir J 2005; 26: Suppl. 49, 694s Year: 2005 Contribution of genetic polymorphism of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, to the susceptibility and severity of non-small cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Genetic polymorphisms of inflammatory cytokines and endothelial dysfunction factors: role in patients with sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Transforming growth factor (TGF)-b1 gene common polymorphisms and plasma TGF-b1 levels in patients with lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 435s Year: 2005 Association of transforming growth factor-ß1 and angiotensinogen G-6A gene polymorphisms influences idiopathic pulmonary fibrosis disease progression Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010